Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM — Stella

Home/Obstructive Hypertrophic Cardiomyopathy/Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

View on ClinicalTrials.gov

Recruiting

Back to Obstructive Hypertrophic Cardiomyopathy trials

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

Trial locations(1 site)

United States

University of Virginia, Charlottesville, Virginia

Key details

Sponsor

Michael Ayers

Collaborators

Bristol-Myers Squibb

Enrollment target

~20 participants

Started

November 2023

Primary completion

August 2026

Age range

18 Years – 85 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.